Middle East & Africa Nerve Repair & Regeneration Market Forecast to 2028

Middle East & Africa Nerve Repair & Regeneration Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Neurostimulation & Neuromodulation Devices {Internal Neurostimulation Devices [Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation] and External Neurostimulation Devices [Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, Respiratory Electrical Stimulation Devices]} and Biomaterials), and Application (Neurostimulation & Neuromodulation Applications {Internal neurostimulation & neuromodulation, and External neurostimulation & neuromodulation}, and Nerve Repair & Regeneration Applications {Direct Nerve Repair/Neurorrhaphy [Epineural Repair, Perineural Repair, and Group Fascicular Repair], Nerve Grafting [Autografts, Allografts, and Xenografts], and Stem cell therapy})

Report Code : BMIRE00027701 | Region : LAMEA | Industry : Medical Device | Published Date : 21/Dec/2022

The nerve repair & regeneration market in the Middle East & Africa is expected to grow from US$ 300.76 million in 2022 to US$ 494.31 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2022 to 2028.

Product Launches and Approvals

Nerve repair and regeneration offers products such as neuromodulators, neurostimulation, and biomaterial devices. These devices are utilized for the treatment of neurodegenerative or traumatic disorders such as Parkinson's disease, Alzheimer's disease, sclerosis, multiple system atrophy, and amyotrophic lateral sclerosis. Therefore, market players are launching various products such as internal neurostimulation devices, external neurostimulation devices, nerve conduits, nerve wraps, nerve connectors, and other biomaterials enhance the treatment output of nerve repair and regeneration. A few of the recent developments related to the nerve repair and regeneration market are In July 2022, Checkpoint Surgical launched the Checkpoint Edge Nerve Cutting Kit, expanding the strength of the intraoperative nerve care portfolio of the company. The Checkpoint Edge Nerve Cutting Kit is the first offering in the planned portfolio of nerve-specific instruments by Checkpoint Surgical, with further expansion planned in the future.

Similarly, In Mar-2022: Integra LifeSciences Holding Corporation launched the NeuraGen 3D Nerve Guide Matrix, which is a resorbable implant for the repair of peripheral nerve discontinuities. NeuraGen 3D is a nerve repair product specifically engineered to develop an optimized environment that enables a greater complete functional recovery following mid-gap nerve repair in comparison to hollow nerve conduits alone. Further, In Aug 2021, Checkpoint Surgical, Inc. launched the NeuroShield Chitosan Nerve Wrap to expand its intraoperative nerve care product line. The NeuroShield Wrap marks is the first product in a planned line of chitosan-based biological implants of the company to support nerve healing. Adding the product, complements the existing product portfolio of Checkpoint Surgical, including the company’s flagship Checkpoint Nerve Stimulator/Locator, the leading nerve stimulation device for intraoperative nerve protection and repair. Thus, the active participation of market players in product innovation and development and increase in approvals of products are likely to fuel the market growth in the coming years.

Market Overview

The Middle East & Africa nerve repair & regeneration market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The growing prevalence of neurological disorders and a surge in research and development activities are driving the growth of the nerve repair & regeneration market. According to WHO, ~80% of strokes are expected to occur in low- and middle-income countries. According to Alzheimer’s disease International, the number of people having Alzheimer’s disease is expected to reach 131.5 million by 2050 in low-and middle-income countries. As per the American Academy of Neurology, in 2022, ~17.6 million (11.7%) DALYs were reported in the region. In the UAE, stroke and dementia are the leading causes of disability-adjusted life years (DALYs) and death. According to WHO, in 2020, in the UAE, ~0.51% of total deaths were due to Parkinson’s disease. The growing geriatric population is significantly increasing the prevalence of Alzheimer’s disease. Thus, the increasing prevalence of neurological diseases among the geriatric population of the UAE is driving the growth of the nerve repair & regeneration market.

Middle East & Africa Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Nerve Repair & Regeneration Market Segmentation

The Middle East & Africa nerve repair & regeneration market is segmented into product, application, and country.

Based on simulator type, the market is segmented into neurostimulation and neuromodulation devices and biomaterial s. The neurostimulation and neuromodulation devices segment registered the largest market share in 2022.

Based on application, the market is categorized into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held the largest market share in 2022.

Based on country, the Middle East & Africa nerve repair & regeneration market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Further, the Rest of MEA dominated the market in 2022.

Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in the Middle East & Africa.

At 8.6% CAGR, the Middle East & Africa Nerve Repair & Regeneration Market is speculated to be worth US$ 494.31 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Middle East & Africa nerve repair & Regeneration Market was valued at US$ 300.76 million in 2022 and is expected to reach US$ 494.31 million by 2028, registering a CAGR of 8.6% from 2022 to 2028. Broadening advancements in stem cell therapy in nerve repair & regeneration and elevating product launches and approvals are the critical factors attributed to the market expansion.

The importance of stem cells as crucial actors in the process of nerve regenerative is noticeable. Consequently, cell-based therapy became a significant and evidenced intervention that improves the functional clinical outcome after nerve injury. In recent years, the technology in constructing tissue-engineered nerve grafts has seen great progress. Incorporating stem cells, such as embryonic stem cells, neural stem cells, bone marrow mesenchymal stem cells, adipose stem cells, skin-derived precursor stem cells, and induced pluripotent stem cells have enhanced the therapeutic effects of tissue-engineered nerve grafts. The high effectiveness of stem cells enlightens the optimistic future of the large-scale clinical use of stem cells. Incorporating stem cells as seed cells into the biomaterial-based scaffolds increases the effectiveness of tissue-engineered nerve grafts and boosts the regenerative process. Numerous stem cells that include neural stem cells, embryonic stem cells, adipose stem cells, skin-derived precursor stem cells, induced pluripotent stem cells, and bone marrow mesenchymal stem cells, have been used in neural tissue engineering. Cell-based therapy for treating peripheral nerve injuries (PNIs) has brought a new perspective to regenerative medicine. Capability to differentiate into glial and neural cells, stem cells improve neural regeneration after PNIs. Augmenting axonal regeneration, remyelination, and muscle mass preservation are the main mechanisms underlying stem cells' valuable effects on neural regeneration. Thus, the advances in stem cell therapy in nerve repair & regeneration is likely to offer growth opportunities for the nerve repair & regeneration market players operating in the region.

On the contrary, elevating dearth of trained professionals hurdles the growth of Middle East & Africa nerve repair & regeneration market.

Based on product type, the Middle East & Africa nerve repair & regeneration market is segmented into neurostimulation and neuromodulation devices biomaterials. The neurostimulation segment held 65.2% market share in 2022, amassing US$ 196.01 million. It is projected to garner US$ 320.60 million by 2028 to expand at 8.5% CAGR during 2022–2028.

Based on application, the Middle East & Africa nerve repair & regeneration market is categorized into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held 60.0% market share in 2022, amassing US$ 180.51 million. It is projected to garner US$ 294.22 million by 2028 to expand at 8.5% CAGR during 2022–2028.

Based on country, the Middle East & Africa nerve repair & regeneration market has been segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Our regional analysis states that the Rest of MEA captured 40.4% market share in 2022. It was assessed at US$ 121.63 million in 2022 and is likely to hit US$ 194.26 million by 2028, exhibiting a CAGR of 8.1% during the forecast period.

Key players dominating the Middle East & Africa nerve repair & Regeneration Market are Axogen Corporation; Boston Scientific Corporation; Integra LifeSciences; Medtronic; Abbott Laboratories; Stryker Corporation; Neuronetics; LivaNova PLC; Baxter; and Polyganics BV, among others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Nerve Repair & Regeneration Market – By Product

1.3.1.1 Neurostimulation and Neuromodulation Devices

1.3.1.2 Biomaterials

1.3.2 Middle East & Africa Nerve Repair & Regeneration Market – By Application

1.3.2.1 Neurostimulation & Neuromodulation Applications

1.3.2.2 Nerve Repair & Regeneration Applications

1.3.3 Middle East & Africa Nerve Repair & Regeneration Market – By Country

2. Middle East & Africa Nerve Repair & Regeneration Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Nerve Repair & Regeneration Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. Middle East & Africa Nerve Repair & Regeneration Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Extending Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders

5.1.2 Increasing Funding by Private and Government Organizations for Research in Neurology

5.2 Key Market Restraints

5.2.1 Dearth of trained professionals

5.3 Key Market Opportunities

5.3.1 Broadening Advancements in Stem Cell Therapy in Nerve Repair & Regeneration

5.4 Future Trend

5.4.1 Elevating Product Launches and Approvals

5.5 Impact analysis

6. Middle East & Africa Nerve Repair & Regeneration Market Analysis

6.1 Middle East & Africa Nerve Repair & Regeneration Market Revenue Forecast and Analysis

7. Middle East & Africa Nerve Repair & Regeneration Market – by Product

7.1 Overview

7.2 By Product: Market Revenue and Forecast Analysis (US$ Million)

7.2.1 Neurostimulation and Neuromodulation Devices

7.2.1.1 Overview

7.2.1.2 Neurostimulation and Neuromodulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3 Internal Neurostimulation Devices

7.2.1.3.1 Overview

7.2.1.3.2 Internal Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.3 Spinal Cord Stimulation

7.2.1.3.3.1 Overview

7.2.1.3.3.2 Spinal Cord Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.4 Deep Brain Stimulation

7.2.1.3.4.1 Overview

7.2.1.3.4.2 Deep Brain Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.5 Vagus Nerve Stimulation

7.2.1.3.5.1 Overview

7.2.1.3.5.2 Vagus Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.6 Sacral Nerve Stimulation

7.2.1.3.6.1 Overview

7.2.1.3.6.2 Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.7 Gastric Electrical Stimulation

7.2.1.3.7.1 Overview

7.2.1.3.7.2 Gastric Electrical Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.4 External Neurostimulation Devices

7.2.1.4.1 Overview

7.2.1.4.2 External Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.4.3 Transcutaneous Electrical Nerve Stimulation Devices

7.2.1.4.3.1 Overview

7.2.1.4.3.2 Transcutaneous Electrical Nerve Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.4.4 Transcranial Magnetic Stimulation Devices

7.2.1.4.4.1 Overview

7.2.1.4.4.2 Transcranial Magnetic Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.4.5 Respiratory Electrical Stimulation Devices

7.2.1.4.5.1 Overview

7.2.1.4.5.2 Respiratory Electrical Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.2 Biomaterials

7.2.2.1 Overview

7.2.2.2 Biomaterials Market Revenue and Forecast to 2028 (US$ Million)

7.2.2.3 Nerve conduits

7.2.2.3.1 Overview

7.2.2.3.2 Nerve conduits Market Revenue and Forecast to 2028 (US$ Million)

7.2.2.4 Nerve wraps

7.2.2.4.1 Overview

7.2.2.4.2 Nerve wraps Market Revenue and Forecast to 2028 (US$ Million)

7.2.2.5 Nerve Connectors

7.2.2.5.1 Overview

7.2.2.5.2 Nerve Connectors Market Revenue and Forecast to 2028 (US$ Million)

7.2.2.6 Other Biomaterials

7.2.2.6.1 Overview

7.2.2.6.2 Other Biomaterials Market Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Nerve Repair & Regeneration Market - by Application

8.1 Overview

8.2 By Application: Market Revenue and Forecast Analysis (US$ Million)

8.2.1 Neurostimulation & Neuromodulation applications

8.2.1.1 Overview

8.2.1.2 Neurostimulation & Neuromodulation applications Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.3 Internal neurostimulation and neuromodulation

8.2.1.3.1 Overview

8.2.1.3.2 Internal neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.4 External neurostimulation and neuromodulation (LBL)

8.2.1.4.1 Overview

8.2.1.4.2 External neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)

8.2.2 Nerve Repair & Regeneration Applications

8.2.2.1 Overview

8.2.2.2 Nerve Repair & Regeneration Applications Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.3 Direct Nerve Repair/Neurorrhaphy

8.2.2.3.1 Overview

8.2.2.3.2 Direct Nerve Repair/Neurorrhaphy Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.3.3 Epineural Repair

8.2.2.3.3.1 Overview

8.2.2.3.3.2 Epineural Repair Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.3.4 Perineural Repair

8.2.2.3.4.1 Overview

8.2.2.3.4.2 Perineural Repair Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.3.5 Group Fascicular Repair

8.2.2.3.5.1 Overview

8.2.2.3.5.2 Group Fascicular Repair Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.4 Nerve Grafting

8.2.2.4.1 Overview

8.2.2.4.2 Nerve Grafting Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.4.3 Autografts

8.2.2.4.3.1 Overview

8.2.2.4.3.2 Autografts Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.4.4 Allografts

8.2.2.4.4.1 Overview

8.2.2.4.4.2 Allografts Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.4.5 Xenografts

8.2.2.4.5.1 Overview

8.2.2.4.5.2 Xenografts Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.5 Stem cell therapy

8.2.2.5.1 Overview

8.2.2.5.2 Stem cell therapy Market Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Nerve Repair & Regeneration Market – Country Analysis

9.1 Overview

9.1.1 Middle East & Africa: Nerve Repair & Regeneration Market, by Country, 2021 & 2028 (%)

9.1.1.1 UAE

9.1.1.1.1 Overview

9.1.1.1.2 UAE: Nerve Repair & Regeneration Market - Revenue and Forecast to 2028 (US$ Million))

9.1.1.1.3 UAE: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million))

9.1.1.1.3.1 UAE: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million))

9.1.1.1.3.2 UAE: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million))

9.1.1.1.4 UAE: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million))

9.1.1.1.4.1 UAE: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million))

9.1.1.1.4.2 UAE: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million))

9.1.1.2 Saudi Arabia

9.1.1.2.1 Overview

9.1.1.2.2 Saudi Arabia: Nerve Repair & Regeneration Market - Revenue and Forecast to 2028 (US$ Million))

9.1.1.2.3 Saudi Arabia: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million))

9.1.1.2.3.1 Saudi Arabia: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million))

9.1.1.2.3.2 Saudi Arabia: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million))

9.1.1.2.4 Saudi Arabia: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million))

9.1.1.2.4.1 Saudi Arabia: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million))

9.1.1.2.4.2 Saudi Arabia: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million))

9.1.1.3 South Africa

9.1.1.3.1 Overview

9.1.1.3.2 South Africa: Nerve Repair & Regeneration Market - Revenue and Forecast to 2028 (US$ Million))

9.1.1.3.3 South Africa: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million))

9.1.1.3.3.1 South Africa: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million))

9.1.1.3.3.2 South Africa: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million))

9.1.1.3.4 South Africa: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million))

9.1.1.3.4.1 South Africa: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million))

9.1.1.3.4.2 South Africa: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million))

9.1.1.4 Rest of Middle East & Africa

9.1.1.4.1 Overview

9.1.1.4.2 Rest of Middle East & Africa: Nerve Repair & Regeneration Market - Revenue and Forecast to 2028 (US$ Million))

9.1.1.4.3 Rest of Middle East & Africa: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million))

9.1.1.4.3.1 Rest of Middle East & Africa: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million))

9.1.1.4.3.2 Rest of Middle East & Africa: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million))

9.1.1.4.4 Rest of Middle East & Africa: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million))

9.1.1.4.4.1 Rest of Middle East & Africa: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million))

9.1.1.4.4.2 Rest of Middle East & Africa: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million))

10. Middle East & Africa Nerve Repair & Regeneration Market – Industry Landscape

10.1 Overview

10.2 Inorganic Growth Strategies

10.2.1 Overview

10.3 Organic Growth Strategies

10.3.1 Overview

11. Company Profiles

11.1 Axogen Corporation

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corporation

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Integra LifeSciences

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Medtronic

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Abbott Laboratories

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Stryker Corporation

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Neuronetics

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 LivaNova PLC

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Baxter

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Polyganics BV

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1. UAE Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million))

Table 2. UAE Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 3. UAE Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 4. UAE Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 5. UAE Nerve Repair & Regeneration Market, by Biomaterials – Revenue and Forecast to 2028 (US$ Million))

Table 6. UAE Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million))

Table 7. UAE Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)

Table 8. UAE Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)

Table 9. UAE Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)

Table 10. UAE Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)

Table 11. Saudi Arabia Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million))

Table 12. Saudi Arabia Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 13. Saudi Arabia Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 14. Saudi Arabia Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 15. Saudi Arabia Nerve Repair & Regeneration Market, by Biomaterials – Revenue and Forecast to 2028 (US$ Million))

Table 16. Saudi Arabia Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million))

Table 17. Saudi Arabia Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)

Table 18. Saudi Arabia Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)

Table 19. Saudi Arabia Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)

Table 20. Saudi Arabia Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)

Table 21. South Africa Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million))

Table 22. South Africa Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 23. South Africa Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 24. South Africa Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 25. South Africa Nerve Repair & Regeneration Market, by Biomaterials – Revenue and Forecast to 2028 (US$ Million))

Table 26. South Africa Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million))

Table 27. South Africa Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)

Table 28. South Africa Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)

Table 29. South Africa Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)

Table 30. South Africa Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million))

Table 32. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 33. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 34. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million))

Table 35. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by Biomaterials – Revenue and Forecast to 2028 (US$ Million))

Table 36. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million))

Table 37. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)

Table 38. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)

Table 39. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)

Table 40. Rest of Middle East & Africa Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)

Table 41. Recent Inorganic Growth Strategies in the Nerve Repair & Regeneration Market

Table 42. Recent Organic Growth Strategies in the Nerve Repair & Regeneration Market

Table 43. Glossary of Terms

LIST OF FIGURES.

Figure 1. Middle East & Africa Nerve Repair & Regeneration Market Segmentation

Figure 2. Middle East & Africa Nerve Repair & Regeneration Market – By Country

Figure 3. Middle East & Africa Nerve Repair & Regeneration Market Overview

Figure 4. Table Top Nerve Repair & Regenerations Held Largest Share by Product of Nerve Repair & Regeneration Market

Figure 5. Rest of MEA to Show Significant Growth During Forecast Period

Figure 6. Middle East & Africa Nerve Repair & Regeneration Market, Industry Landscape

Figure 7. Middle East & Africa: PEST Analysis

Figure 8. Experts Opinion

Figure 9. Middle East & Africa Nerve Repair & Regeneration market impact analysis of driver and restraints

Figure 10. Middle East & Africa Nerve Repair & Regeneration Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 11. By Product: Market Analysis and Forecast 2021 and 2028 (%)

Figure 12. Neurostimulation and Neuromodulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Internal Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Spinal Cord Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. Deep Brain Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. Vagus Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 17. Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 18. Gastric Electrical Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 19. External Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 20. Transcutaneous Electrical Nerve Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 21. Transcranial Magnetic Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 22. Respiratory Electrical Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 23. Biomaterials Market Revenue and Forecast to 2028 (US$ Million)

Figure 24. Nerve conduits Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. Nerve wraps Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. Nerve Connectors Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. Other Biomaterials Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. By Application: Market Analysis and Forecast 2021 and 2028 (%)

Figure 29. Neurostimulation & Neuromodulation applications Market Revenue and Forecast to 2028 (US$ Million)

Figure 30. Internal neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 31. External neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 32. Nerve Repair & Regeneration Applications Market Revenue and Forecast to 2028 (US$ Million)

Figure 33. Direct Nerve Repair/Neurorrhaphy Market Revenue and Forecast to 2028 (US$ Million)

Figure 34. Epineural Repair Market Revenue and Forecast to 2028 (US$ Million)

Figure 35. Perineural Repair Market Revenue and Forecast to 2028 (US$ Million)

Figure 36. Group Fascicular Repair Market Revenue and Forecast to 2028 (US$ Million)

Figure 37. Nerve Grafting Market Revenue and Forecast to 2028 (US$ Million)

Figure 38. Autografts Market Revenue and Forecast to 2028 (US$ Million)

Figure 39. Allografts Market Revenue and Forecast to 2028 (US$ Million)

Figure 40. Xenografts Market Revenue and Forecast to 2028 (US$ Million)

Figure 41. Stem cell therapy Market Revenue and Forecast to 2028 (US$ Million)

Figure 42. Middle East & Africa: Nerve Repair & Regeneration Market, by Key Country – Revenue (2022) (US$ Million))

Figure 43. UAE Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)

Figure 44. Saudi Arabia Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)

Figure 45. South Africa Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)

Figure 46. Rest of Middle East & Africa Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)

● Axogen Corporation

● Boston Scientific Corporation

● Integra LifeSciences

● Medtronic

● Abbott Laboratories

● Stryker Corporation

● Neuronetics

● LivaNova PLC

● Baxter

● Polyganics BV

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa nerve repair & regeneration market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa nerve repair & regeneration market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the nerve repair & regeneration market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP